Literature DB >> 16104456

The economics of hospital reform from hierarchical to market-based incentives.

Alexander S Preker1, April Harding.   

Abstract

Heavy investment over the past 30 years has made the hospital sector the largest expenditure category of the health system in most developed and developing countries. In most countries hospitals remain a critical link to health care, providing both advanced and basic care for the population. Often, they are the provider 'of last resort' for the poor and critically ill. This article provides insights into recent hospital reforms undertaken throughout the world, with an emphasis on organisational changes such as increased management autonomy, corporatisation, and privatisation. It provides some insights about these popular reform modalities from a review of the literature, reform experiences in other sectors and empirical evidence from hospital sector itself. The material presented tries to answer three questions: (a) what problems did this type of reform try to address; (b) what are the core elements of their design, implementation and evaluation; and, (c) is there any evidence that this type of reform is successful in addressing problems for which they were intended? While this paper focuses on issues related to the design of the reforms, the paper also reports the findings from a larger study that examined the implementation and evaluation of such reforms so that they will be available to countries that are considering venturing down this reform path.

Mesh:

Year:  2005        PMID: 16104456

Source DB:  PubMed          Journal:  World Hosp Health Serv        ISSN: 1029-0540


  2 in total

1.  Selecting the most suitable organizational structure for hospitals: an integrated fuzzy FUCOM-MARCOS method.

Authors:  Mohsen Khosravi; Arash Haqbin; Zahra Zare; Payam Shojaei
Journal:  Cost Eff Resour Alloc       Date:  2022-06-27

2.  The effects of diagnosis-related groups payment on efficiency of the hospital health care in Croatia.

Authors:  Karolina Kalanj; Rick Marshall; Karl Karol; Stjepan Orešković
Journal:  Croat Med J       Date:  2021-12-31       Impact factor: 1.351

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.